SKI Market

A+| A| A-|

Indian Indices

Sensex

73,419.24 284.92
( 0.39%)

Global Indices

Nasdaq

46,577.55 215.03
(0.46%)

Dow Jones

6,594.89 45.37
(0.69%)

Hang Seng

52,384.74 -1,354.94
(-2.52%)

Nikkei 225

10,364.79 188.34
(1.85%)

Forex

USD-INR

93.85 -0.46
(-0.49%)

EUR-INR

107.97 -0.33
(-0.30%)

GBP-INR

124.03 -0.65
(-0.52%)

JPY-INR

0.59 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sameera Agro and Infra Ltd

Industry : Food - Processing - Indian

BSE Code

ISIN Demat

Book Value()

91892

INE0PZA01015

14.3164789

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SAIFL

4.49

52.7

EPS(TTM)

Face Value()

Div & Yield %

1.97

Back

Natco Pharma receives USFDA EIR report for API unit in Chennai

Feb 13,2026

NATCO Pharma announced that the U.S. Food and Drug Administration (FDA) had conducted an inspection at the Active Pharmaceutical Ingredient Division located in Manali, Chennai from 17 November – 21 November 2025. The Company received seven (7) observation in the Form-483.

Further, the Company has received the EIR (Establishment Inspection Report) from the USFDA on the classification of the above-referred inspection as Voluntary Action Indicated (VAI).

73,419.24 284.92 ( 0.39%)

46,577.55 215.03 (0.46%)

6,594.89 45.37 (0.69%)

52,384.74 -1,354.94 (-2.52%)

10,364.79 188.34 (1.85%)

93.85 -0.46 (-0.49%)

107.97 -0.33 (-0.30%)

124.03 -0.65 (-0.52%)

0.59 0.00 (-0.26%)